EKF Diagnostics Holdings plc (LON:EKF) Insider Gavin T. Jones Buys 50,000 Shares

EKF Diagnostics Holdings plc (LON:EKF) insider Gavin T. Jones purchased 50,000 shares of the firm’s stock in a transaction on Tuesday, March 25th. The stock was bought at an average price of GBX 22 ($0.28) per share, with a total value of £11,000 ($14,237.64).

EKF Diagnostics Price Performance

LON:EKF opened at GBX 21.90 ($0.28) on Friday. The company has a current ratio of 4.60, a quick ratio of 1.77 and a debt-to-equity ratio of 0.34. The firm has a fifty day simple moving average of GBX 23.04 and a 200 day simple moving average of GBX 25.78. EKF Diagnostics Holdings plc has a 1-year low of GBX 18.40 ($0.24) and a 1-year high of GBX 33.80 ($0.44). The stock has a market capitalization of £97.34 million, a PE ratio of 20.38 and a beta of 0.57.

EKF Diagnostics (LON:EKF) last released its quarterly earnings data on Tuesday, March 25th. The company reported GBX 1.38 ($0.02) earnings per share for the quarter. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%. On average, research analysts expect that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current fiscal year.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.